Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.
about
Measuring the value of public health systems: the disconnect between health economists and public health practitionersMass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations.Inborn errors of metabolism identified via newborn screening: Ten-year incidence data and costs of nutritional interventions for research agenda planningSpecific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screeningRapid genotyping of single nucleotide polymorphisms influencing warfarin drug response by surface-enhanced laser desorption and ionization time-of-flight (SELDI-TOF) mass spectrometry.Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis.The laboratory test utilization management toolbox.Incidence and patterns of inborn errors of metabolism in the Eastern Province of Saudi Arabia, 1983-2008Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France.A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID).The incidence of inherited metabolic disorders in the West Midlands, UK.Economic analyses of human genetics services: a systematic review.The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update.The Role of Information Provision in Economic Evaluations of Newborn Bloodspot Screening: A Systematic ReviewNewborn screening in Canada - Are we out of step?Impact of false-positive newborn metabolic screening results on early health care utilization.QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique.Biomarkers in pediatrics: children as biomarker orphans.Inborn errors of metabolism and expanded newborn screening: review and update.Fiscal implications of newborn screening in the diagnosis of severe combined immunodeficiency.Cost-benefit analysis of hyperphenylalaninemia due to 6-pyruvoyl-tetrahydropterin synthase (PTPS) deficiency: for consideration of expanded newborn screening in Hong Kong.
P2860
Q24657827-217778A3-5C07-4283-B898-B16E1FE3076DQ30751781-5BB58896-2038-4610-975A-C9C9B3C0D94FQ30840211-756F3FE2-C396-4627-B47A-154B4A7BE14DQ31088945-BAB4D412-3B91-49FD-B43D-F8856B05019EQ33523960-8237EC5A-B0B1-4DE1-8449-4941ECE2C2EEQ33589004-4492361E-2AC3-4602-A637-103591A37C24Q33852095-D88231F6-9E0B-4223-907A-4A6ADBCF0114Q34099238-EE4F6A03-042A-4D7C-AD4A-8F0CE413F8ECQ34297808-16C79E79-D640-4A18-B3C9-69C84E2B6593Q35488784-FD9AFDE5-BE02-427E-ACD4-7AD122A4D524Q36153326-C16C8701-BFFD-4939-A972-22DB86E5675DQ36296074-8CD6F315-3E23-4A1B-9760-BA472F82796DQ36450404-CB304838-8602-4B07-A9B6-1C54021C049EQ36573343-F2FF54B0-E3EA-4EEE-8E83-108D6AB579ACQ37293873-9A15283E-3486-4834-8E1D-371177CD25DDQ37411500-9C30A15D-69F0-456B-B16E-BE0D493C0650Q37764874-09C063B6-9016-47DD-B804-908F7D2789E1Q37817271-8FB379D1-767D-4F80-ABF9-5977A6A0A321Q38167824-98F4C23C-D66D-4BBE-97D9-E6A507CA3323Q46527875-9C8B2824-8352-4A03-8EB7-C12AB13D8C05Q51246313-95FD7B79-A7AD-4E34-85A5-65E676747C51
P2860
Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Newborn screening by tandem ma ...... a cost-effectiveness analysis.
@ast
Newborn screening by tandem ma ...... a cost-effectiveness analysis.
@en
type
label
Newborn screening by tandem ma ...... a cost-effectiveness analysis.
@ast
Newborn screening by tandem ma ...... a cost-effectiveness analysis.
@en
prefLabel
Newborn screening by tandem ma ...... a cost-effectiveness analysis.
@ast
Newborn screening by tandem ma ...... a cost-effectiveness analysis.
@en
P2093
P356
P1433
P1476
Newborn screening by tandem ma ...... a cost-effectiveness analysis.
@en
P2093
Charles P Venditti
Edward M Kaye
Henry Glick
Laura N Venditti
Paige B Kaplan
P304
P356
10.1542/PEDS.112.5.1005
P407
P577
2003-11-01T00:00:00Z